Release PM
Release PM, licence 80014766: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Sleep Plus, Sleep Well, SleepAid, SleepAid PM
- Licence holder
- Natural Equivalents Incorporated
- NPN or DIN-HM
- 80014766
- Status
- Active licence
- Licence date
- 17 November 2009
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Passiflora incarnata Source : Parties aériennes Extraction ratio : 1:1 Dry plant equivalent : 308 mg | 0.077 mL | Not calculated |
Non-medicinal ingredients
Acide citrique, stevia, Sorbate de potassium, Alcool, Eau purifiée, Natural blueberry flavour
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.5 mL | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule. Helps to reduce the time it takes to fall asleep in people with delayed sleep phase syndrome.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80014766
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.